March Altus Capital Management LP - Q1 2016 holdings

$9.67 Million is the total value of March Altus Capital Management LP's 9 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 30.0% .

 Value Shares↓ Weighting
LLY BuyLILLY ELI & CO$1,931,000
+157.5%
26,810
+201.3%
19.98%
+189.6%
EW SellEDWARDS LIFESCIENCES CORP$1,539,000
+407.9%
17,443
-54.5%
15.92%
+471.3%
DXCM  DEXCOM INC$1,293,000
-17.1%
19,0460.0%13.38%
-6.8%
PETX  ARATANA THERAPEUTICS INC$1,206,000
-1.1%
218,5150.0%12.48%
+11.3%
ALXN  ALEXION PHARMACEUTICALS INC$1,197,000
-27.0%
8,5990.0%12.38%
-17.9%
REGN SellREGENERON PHARMACEUTICALS$826,000
-47.8%
2,291
-21.4%
8.55%
-41.3%
ATHN  ATHENAHEALTH INC$680,000
-13.8%
4,9000.0%7.04%
-3.1%
ACAD SellACADIA PHARMACEUTICALS INC$603,000
-43.2%
21,552
-27.7%
6.24%
-36.1%
ALGN NewALIGN TECHNOLOGY INC$390,0005,366
+100.0%
4.04%
AERI ExitAERIE PHARMACEUTICALS INC$0-14,962
-100.0%
-3.35%
INCY ExitINCYTE CORP$0-14,756
-100.0%
-14.72%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DEXCOM INC12Q3 201614.4%
LILLY ELI & CO12Q3 201620.0%
ALEXION PHARMACEUTICALS INC11Q3 201615.1%
MALLINCKRODT PUB LTD CO8Q3 20157.0%
UNITED THERAPEUTICS CORP DEL7Q3 201511.7%
REGENERON PHARMACEUTICALS7Q3 201614.6%
UNIVERSAL HLTH SVCS INC7Q2 201512.1%
ZOETIS INC7Q3 20165.2%
INCYTE CORP6Q4 201514.7%
EDWARDS LIFESCIENCES CORP5Q3 201628.5%

View March Altus Capital Management LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2016-11-07
13F-HR2016-07-27
13F-HR2016-05-12
13F-HR2016-02-16
13F-HR2015-11-16
13F-HR2015-08-14
13F-HR2015-05-15
13F-HR2015-02-17
13F-HR2014-11-14
13F-HR2014-08-14

View March Altus Capital Management LP's complete filings history.

Compare quarters

Export March Altus Capital Management LP's holdings